Z-1660-2023 Class II Ongoing

Recalled by Maquet Medical Systems USA — Wayne, NJ

FDA device recall Z-1660-2023 was initiated by Maquet Medical Systems USA on May 18, 2023 and is designated Class II. Reason for recall: Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation… The recall status is ongoing. Affected quantity: 0 (US).

Recall details

Product Type
Devices
Report Date
Jun 7, 2023
Initiation Date
May 18, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
0 (US)

Product description

QUADROX -i Neonatal, Oxygenator used during cardiopulmonary bypass Model Item No. HMO 10000-USA 701070412 HMO 11000-USA 701070416

Reason for recall

Product packaging may exhibit small pinholes which may not be visible to the unaided eye, compromising the sterile barrier of the packaging. Exposure to non-sterile device may result in inflammation, infection, sepsis, and ischemia.

Distribution pattern

Nationwide domestic distribution

Code information

Model Item No. UDI HMO 10000-USA 701070412 4058863154473 HMO 11000-USA 701070416 4058863154558 All lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1660-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1660-2023. Report a data issue: hello@regdatalab.com.